ALK-Abello A/S (AKBLF)
37.92
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
ALK-Abello Price to Book Value : 7.923 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 7.923 |
| August 27, 2026 | 7.923 |
| August 26, 2026 | 7.923 |
| August 25, 2026 | 7.923 |
| August 24, 2026 | 7.923 |
| August 21, 2026 | 7.923 |
| August 20, 2026 | 7.923 |
| August 19, 2026 | 7.923 |
| August 18, 2026 | 7.923 |
| August 17, 2026 | 7.923 |
| August 14, 2026 | 7.923 |
| August 13, 2026 | 7.923 |
| August 12, 2026 | 7.923 |
| August 11, 2026 | 7.923 |
| August 10, 2026 | 7.923 |
| August 07, 2026 | 7.923 |
| August 06, 2026 | 7.923 |
| August 05, 2026 | 7.923 |
| August 04, 2026 | 7.923 |
| August 03, 2026 | 7.923 |
| July 31, 2026 | 7.923 |
| July 30, 2026 | 7.923 |
| July 29, 2026 | 7.923 |
| July 28, 2026 | 7.923 |
| July 27, 2026 | 7.923 |
| Date | Value |
|---|---|
| July 24, 2026 | 7.923 |
| July 23, 2026 | 7.923 |
| July 22, 2026 | 7.923 |
| July 21, 2026 | 7.923 |
| July 20, 2026 | 7.923 |
| July 17, 2026 | 7.923 |
| July 16, 2026 | 7.923 |
| July 15, 2026 | 8.494 |
| July 14, 2026 | 8.494 |
| July 13, 2026 | 8.494 |
| July 10, 2026 | 8.494 |
| July 09, 2026 | 8.494 |
| July 08, 2026 | 8.494 |
| July 07, 2026 | 8.494 |
| July 06, 2026 | 8.494 |
| July 02, 2026 | 8.494 |
| July 01, 2026 | 8.494 |
| June 30, 2026 | 8.494 |
| June 29, 2026 | 8.893 |
| June 26, 2026 | 8.893 |
| June 25, 2026 | 8.893 |
| June 24, 2026 | 8.893 |
| June 23, 2026 | 8.893 |
| June 22, 2026 | 8.893 |
| June 18, 2026 | 8.893 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Novo Nordisk A/S | 5.958 |
| H. Lundbeck A/S | 1.680 |
| AstraZeneca PLC | 10.66 |
| ANI Pharmaceuticals, Inc. | 2.802 |
| Corcept Therapeutics, Inc. | 17.41 |
Price to Book Value Related Metrics
| PE Ratio | 39.68 |
| PS Ratio | 7.882 |
| PEG Ratio | 0.8704 |
| Price to Free Cash Flow | 29.74 |
| Price | 37.92 |
| Earnings Yield | 2.52% |
| Market Cap | 8.413B |
| PEGY Ratio | 0.8579 |
| Operating PE Ratio | 29.50 |
| Normalized PE Ratio | 39.68 |